Eye Drop

After receiving a warning letter from the FDA, the online retailer Amazon removed seven unregulated eye drop products from its website.

The recent FDA warning about 26 potentially contaminated eye drop products, including some marketed under CVS Health, Leader, Rugby, Rite Aid, Target Up&Up and Velocity Pharma, may have caused some confusion among consumers.

SAN FRANCISCO — An eye drop improved visual acuity in patients with diabetic macular edema, according to a study presented at Retina Subspecialty Day at the American Academy of Ophthalmology meeting.

The Harvard Drug Group and Cardinal Health have initiated voluntary recalls on certain over-the-counter ophthalmic products after the FDA warned about unsanitary conditions in the manufacturing facility.

Dry eye disease is chronic, multifactorial and complex. As a result, management plans have to account for many variables, from underlying conditions to work environments.

NEW ORLEANS — Research presented at Academy ’23 demonstrated that perfluorohexyloctane, which is indicated for dry eye disease, reduces corneal staining up to four times more than saline.

In this Healio Video Perspective, Cathleen M. McCabe, MD, discusses a presentation from the ESCRS meeting on phentolamine 0.75%.

VIENNA — During the “presbyopia game changers” symposium at the ESCRS meeting, Elizabeth Yeu, MD, gave an update on pharmacological treatment.

Bausch + Lomb has announced the U.S. commercial launch of Miebo, a perfluorohexyloctane ophthalmic solution designed to treat signs and symptoms of dry eye disease by directly targeting tear evaporation.

Pilocarpine hydrochloride 1.25% administered twice daily yielded statistically greater near-vision improvements than a control vehicle, while maintaining the safety profile of once-daily administration, according to research.